RENEW
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
More Information
- Trial Status
- Accepting patients
- Trial Phase
- Phase 3
- Enrollment
- 225 patients (estimated)
- Collaborators
- PSI CRO
- Tags
- Activin Receptor IIA Inhibitor, Placebo, Closed Label (Masked), Randomization
- Trial Type
- Treatment
- Last Update
- SparkCures ID
- 2037
- NCT Identifier
- NCT06499285
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.